MAPT and Alzheimer disease: AD manifests as a progressive decline in cognitive abilities, accompanied by brain atrophy, the accumulation of amyloid β (Aβ) plaques in the brain’s parenchyma, and the formation of hyperphosphorylated tau protein aggregates within neurons [10].